Construction on the Universities at Shady Grove’s new biomedical sciences and engineering building is scheduled to begin this fall after local leaders persuaded Gov. Larry Hogan to reinstate funding for the project during this year’s General Assembly session.
Two biotech companies in the United States have been given the green light to see if it is possible to regenerate the brains of dead people. © Shutterstock Bioquark Inc., in collaboration with Revita Life Sciences, has been given ethical permission by US health authorities to recruit 20 patients who have been declared clinically dead from a traumatic brain injury to test whether parts of their central nervous system (CNS) can be brought back to life.
This week, MdBioLab was featured on ABC7 (WJLA) and Montgomery Community Media (MCM). In the ABC7 piece, MdBioLab was on location at Dr. Henry A. Wise Jr. High School in Upper Marlboro. Students were engaged in one of MdBioLab’s more popular activities, Mystery of the Crooked Cell in which they learn how to diagnose sickle cell disease at the molecular level. Working to achieve MdBio Foundation’s mission, MdBioLab brought the students access to laboratory equipment that many had never used before.
And the Winners are…
Innovation
Corporate Excellence
Entrepreneur
Please join TEDCO at our annual ICE Awards, as we honor some of our “coolest” portfolio companies and recognize the best and brightest that are developing cutting-edge technologies and enriching our community.
Meet with 20 of TEDCO’s recently funded startup companies that will be exhibiting.
Network with the hottest tech startups, investors and entrepreneurship community in Maryland.
Investment firm Heritage Group has closed its second innovation fund and now counts 15 healthcare organizations as limited partners.
The $220 million fund is the latest example of how health systems and other industry players are taking an active role in piloting, investing in and mentoring young digital health companies as technology continues to reshape healthcare delivery. It is among the largest pools of funds for healthcare technology investments, and the combined approach allows the group to make larger investments in later-stage companies than they might otherwise do on their own.
Under the leadership of Prime Minister Narendra Modi, the Indian government has shown that it understands the need to develop innovation in the country’s health care sector.
Baltimore was a major site in the effort to develop an Ebola vaccine. Two years later, a leading Johns Hopkins researcher is looking to apply a major discovery to the Zika virus.
J. Thomas August, a JHU pharmacology and molecular sciences professor, formed Pharos Biologicals in December. The company received a license to develop DNA vaccine technology called the LAMP for influenza and flaviviruses from the Johns Hopkins School of Medicine.
GlaxoSmithKline CEO Andrew Witty attributes the company’s success to sticking to the tried-and-true business model of investing in research and development and not transitioning to an acquisition model.
Witty told CNBC’s “Closing Bell” on Monday that the key is to be patient and to see the value of investing in innovation.
Lita Nelsen is one of the most influential power brokers in the drug industry — and yet there’s a good chance you’ve never heard of her.
That’s because she ran one of the country’s largest and most successful technology transfer offices, an unglamorous yet essential go-between for universities and startups. And any time a venture capitalist, a pharmaceutical company, or a tech titan wanted to cash in on an invention at the Massachusetts Institute of Technology, each had to go through her.
Orthopedic surgeons are relying more and more on 3-D printing to build replacements for their patients’ defective or worn out bones.
This year surgeons around the world will implant tens of thousands of 3-D printed replacements parts for hips, knees, ankles, parts of the spine, and even sections of the skull.
